logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Thomas A. Abrams

harvard university medical affiliates
H指数:37
被引数:6,116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030

HCC-CARE Symposium总结：到2030年在波士顿实现肝细胞癌公平性的协作方法

Journal of Hepatocellular Carcinoma
IF3.4
2025-07-160
OA
Kelsey S Lau-Min; Thomas Abrams; Andrea Bullock; Alyson Kaplan; Leslie Salas Karnes; Mark W Kennedy; Christina A LeBedis; Ming V Lin; Nadine Jackson McCleary; Shirin Sioshansi; Emma Voligny; Elizabeth Paige Walsh; Christopher R Manz; On behalf of HCC-CARE
An open label, phase II trial of ERK inhibition alone and in combination with autophagy inhibition in patients with metastatic cancreatic cancer
CANCER RESEARCH
IF16.6
2024-09-150
PRE
Surana, Rishi; Zheng, Hui; Wang, Junning; Morgado, Micaela; Brais, Lauren K.; Bryant, Kirsten L.; Somasundaram, Ashwin; Weekes, Colin D.; Bockorny, Bruno; Peters, Mary Linton B.; Bullock, Andrea J.; Zerillo, Jessica A.; Rattani, Ahmed A.; Sanoff, Hanna K.; Clark, Jeffrey W.; Parikh, Aparna R.; Yurgelun, Matthew B.; Patel, Anuj; Mayer, Robert J.; Cleary, James M.; Enzinger, Peter C.; Rubinson, Douglas A.; McCleary, Nadine J.; Enzinger, Andrea C.; Slater, Sarah E.; Ng, Kimmie; Abrams, Thomas A.; Biller, Leah; Raghavan, Srivatsan; Mancias, Joseph D.; Nowak, Jonathan O.; Aguirre, Andrew J.; Der, Channing J.; Wolpin, Brian M.; Perez, Kimberley
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+gastroesophageal adenocarcinoma
NATURE COMMUNICATIONS
IF15.7
2024-08-091
OAAI
Singh, Harshabad; Lowder, Kristen E.; Kapner, Kevin; Kelly, Ronan J.; Zheng, Hui; McCleary, Nadine Jackson; Abrams, Thomas A.; Chan, Jennifer A.; Regan, Eileen M.; Klempner, Samuel J.; Hannigan, Alison M.; Remland, Joshua; Brais, Lauren K.; Andrews, Elizabeth; Yurgelun, Matthew; Cleary, James M.; Rubinson, Douglas A.; Ritterhouse, Lauren L.; Maron, Garrett; Aguirre, Andrew J.; Meyerhardt, Jeffrey A.; Gardecki, Emma; Lennerz, Jochen K.; Wolpin, Brian M.; Enzinger, Peter C.
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer

FOENIX-CCA2研究的简明语言摘要: futibatinib用于晚期胆管癌患者

FUTURE ONCOLOGY
IF2.6
2024-06-170
OAAI
Goyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A.
A phase 1 expansion cohort study evaluating the safety and efficacy of the CHK1 inhibitor LY2880070 with low-dose gemcitabine in metastatic pancreatic adenocarcinoma
CANCER RESEARCH
IF16.6
2024-01-160
PRE
Huffman, Brandon M.; Feng, Hanrong; Parmar, Kalindi; Wang, Junning; Kapner, Kevin; Kochupurakkal, Bose; Martignetti, David; Abrams, Thomas; Biller, Leah; Giannakis, Marios; Ng, Kimmie; Patel, Anuj; Perez, Kimberly; Singh, Harshabad; Rubinson, Douglas; Schlechter, Benjamin; Andrews, Elizabeth; Hannigan, Alison; Dunwell, Stanley; Getchell, Zoe; Raghavan, Srivatsan; Wolpin, Brian; D'Andrea, Alan; Aguirre, Andrew; Shapiro, Geoffrey; Cleary, James
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
CLINICAL CANCER RESEARCH
IF10.2
2023-10-114
OA
Huffman, Brandon M.; Feng, Hanrong; Parmar, Kalindi; Wang, Junning; Kapner, Kevin S.; Kochupurakkal, Bose; Martignetti, David B.; Sadatrezaei, Golbahar; Abrams, Thomas A.; Biller, Leah H.; Giannakis, Marios; Ng, Kimmie; Patel, Anuj K.; Perez, Kimberly J.; Singh, Harshabad; Rubinson, Douglas A.; Schlechter, Benjamin L.; Andrews, Elizabeth; Hannigan, Alison M.; Dunwell, Stanley; Getchell, Zoe; Raghavan, Srivatsan; Wolpin, Brian M.; Fortier, Caroline; D'Andrea, Alan D.; Aguirre, Andrew J.; Shapiro, Geoffrey I.; Cleary, James M.
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

PD-1阻断诱导胰腺癌患者以nf-κb信号为特征的非生产性T细胞反应的重新激活

CLINICAL CANCER RESEARCH
IF10.2
2023-09-210
OAAI
Ali, Lestat R.; Lenehan, Patrick J.; Cardot-Ruffino, Victoire; Dias Costa, Andressa; Katz, Matthew H. G.; Bauer, Todd W.; Nowak, Jonathan A.; Wolpin, Brian M.; Abrams, Thomas A.; Patel, Anuj; Clancy, Thomas E.; Wang, Jiping; Mancias, Joseph D.; Reilley, Matthew J.; Stucky, Chee-Chee H.; Bekaii-Saab, Tanios S.; Elias, Rawad; Merchant, Nipun; Slingluff, Craig L.; Rahma, Osama E.; Dougan, Stephanie K.
Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

胆道癌，2.2023版更新了NCCN指南

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2023-07-0171
OA
Benson, Al B., III; D'Angelica, Michael I.; Abrams, Thomas; Abbott, Daniel E.; Ahmed, Aijaz; Anaya, Daniel A.; Anders, Robert; Are, Chandrakanth; Bachini, Melinda; Binder, David; Borad, Mitesh; Bowlus, Christopher; Brown, Daniel; Burgoyne, Adam; Castellanos, Jason; Chahal, Prabhleen; Cloyd, Jordan; Covey, Anne M.; Glazer, Evan S.; Hawkins, William G.; Iyer, Renuka; Jacob, Rojymon; Jennings, Lawrence; Kelley, R. Kate; Kim, Robin; Levine, Matthew; Palta, Manisha; Park, James O.; Raman, Steven; Reddy, Sanjay; Ronnekleiv-Kelly, Sean; Sahai, Vaibhav; Singh, Gagandeep; Stein, Stacey; Turk, Anita; Vauthey, Jean-Nicolas; Venook, Alan P.; Yopp, Adam; McMillian, Nicole; Schonfeld, Ryan; Hochstetler, Cindy
Long term results and ctDNA correlatives for CAPOX BETR: A multi-center phase II trial of capecitabine, oxaliplatin, bevacizumab and trastuzumab for previously untreated HER2 positive metastatic gastroesophageal adenocarcinoma
CANCER RESEARCH
IF16.6
2023-04-140
PRE
Singh, Harshabad; Lowder, Kristen E.; Kapner, Kevin; Kelly, Ronan J.; Zheng, Hui; McCleary, Nadine J.; Abrams, Thomas A.; Chan, Jennifer A.; Regan, Eileen M.; Klempner, Samuel J.; Hannigan, Alison M.; Brais, Lauren K.; Andrews, Elizabeth A.; Yurgelun, Matthew B.; Cleary, James M.; Rubinson, Douglas A.; Ritterhouse, Lauren L.; Maron, Garrett E.; Aguirre, Andrew J.; Tan, Lu; Du, Pan; Meyerhardt, Jeffrey A.; Gardecki, Emma; Lennerz, Jochen K.; Jia, Shidong; Wolpin, Brian M.; Enzinger, Peter C.
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

在BRAFV600E结直肠癌中联合PD-1，BRAF和MEK抑制: 一项2期试验

NATURE MEDICINE
IF50
2023-01-2678
OAAI
Tian, Jun; Chen, Jonathan H. H.; Chao, Sherry X. X.; Pelka, Karin; Giannakis, Marios; Hess, Julian; Burke, Kelly; Jorgji, Vjola; Sindurakar, Princy; Braverman, Jonathan; Mehta, Arnav; Oka, Tomonori; Huang, Mei; Lieb, David; Spurrell, Maxwell; Allen, Jill N. N.; Abrams, Thomas A. A.; Clark, Jeffrey W. W.; Enzinger, Andrea C. C.; Enzinger, Peter C. C.; Klempner, Samuel J. J.; McCleary, Nadine J. J.; Meyerhardt, Jeffrey A. A.; Ryan, David P. P.; Yurgelun, Matthew B. B.; Kanter, Katie; Van Seventer, Emily E. E.; Baiev, Islam; Chi, Gary; Jarnagin, Joy; Bradford, William B. B.; Wong, Edmond; Michel, Alexa G. G.; Fetter, Isobel J. J.; Siravegna, Giulia; Gemma, Angelo J. J.; Sharpe, Arlene; Demehri, Shadmehr; Leary, Rebecca; Campbell, Catarina D. D.; Yilmaz, Omer; Getz, Gad A. A.; Parikh, Aparna R. R.; Hacohen, Nir; Corcoran, Ryan B. B.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma

Futibatinib治疗FGFR2-Rearranged肝内胆管癌

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-01-19243
OA
Goyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin K.; Cassier, Philippe A.; Kluempen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Mitchell, Edith P.; Komatsu, Yoshito; Masuda, Kunihiro; Ahn, Daniel; Epstein, Robert S.; Halim, Abdel-Baset; Fu, Yao; Salimi, Tehseen; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A.
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
CANCER DISCOVERY
IF33.3
2021-04-2961
OA
Cleary, James M.; Raghavan, Srivatsan; Wu, Qibiao; Li, Yvonne Y.; Spurr, Liam F.; Gupta, Hersh, V; Rubinson, Douglas A.; Fetter, Isobel J.; Hornick, Jason L.; Nowak, Jonathan A.; Siravegna, Giulia; Goyal, Lipika; Shi, Lei; Brais, Lauren K.; Loftus, Maureen; Shinagare, Atul B.; Abrams, Thomas A.; Clancy, Thomas E.; Wang, Jiping; Patel, Anuj K.; Brichory, Franck; Chessex, Anne Vaslin; Sullivan, Ryan J.; Keller, Rachel B.; Denning, Sarah; Hill, Emma R.; Shapiro, Geoffrey, I; Pokorska-Bocci, Anna; Zanna, Claudio; Ng, Kimmie; Schrag, Deborah; Janne, Pasi A.; Hahn, William C.; Cherniack, Andrew D.; Corcoran, Ryan B.; Meyerson, Matthew; Daina, Antoine; Zoete, Vincent; Bardeesy, Nabeel; Wolpin, Brian M.

研究方向

暂未获取到该数据
B
Brian M. Wolpin
H 指数:88论文数:1,210被引数:3.0万
N
Nadine J. McCleary
H 指数:25论文数:204被引数:3,587
P
Peter C. Enzinger
H 指数:62论文数:352被引数:2.5万
C
Charles S. Fuchs
H 指数:171论文数:1,724被引数:11.3万
L
Lipika Goyal
H 指数:57论文数:609被引数:1.8万
K
Kimmie Ng
H 指数:68论文数:793被引数:1.8万
J
Jeffrey A. Meyerhardt
H 指数:116论文数:1,054被引数:5.3万
D
David P. Ryan
H 指数:91论文数:938被引数:3.5万
D
Douglas A. Rubinson
H 指数:37论文数:417被引数:7,688
J
James M. Cleary
H 指数:52论文数:733被引数:1.9万